These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27503607)

  • 41. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
    Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z
    Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
    Kashyap S; Singh N; Surnar B; Jayakannan M
    Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intelligent "Peptide-Gathering Mechanical Arm" Tames Wild "Trojan-Horse" Peptides for the Controlled Delivery of Cancer Nanotherapeutics.
    Shi NQ; Li Y; Zhang Y; Shen N; Qi L; Wang SR; Qi XR
    ACS Appl Mater Interfaces; 2017 Dec; 9(48):41767-41781. PubMed ID: 29161013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted theranostic prodrugs based on an aggregation-induced emission (AIE) luminogen for real-time dual-drug tracking.
    Yuan Y; Kwok RT; Zhang R; Tang BZ; Liu B
    Chem Commun (Camb); 2014 Oct; 50(78):11465-8. PubMed ID: 25137179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs.
    Nasrolahi Shirazi A; Tiwari R; Chhikara BS; Mandal D; Parang K
    Mol Pharm; 2013 Feb; 10(2):488-99. PubMed ID: 23301519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Construction and application of targeted drug delivery system based on hyaluronic acid and heparin functionalised carbon dots.
    Duan Q; Ma L; Zhang B; Zhang Y; Li X; Wang T; Zhang W; Li Y; Sang S
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110768. PubMed ID: 31945629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study.
    Aroui S; Brahim S; Waard MD; Kenani A
    Biochem Biophys Res Commun; 2010 Jan; 391(1):419-25. PubMed ID: 19914216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel cleavable cell-penetrating peptide-drug conjugates: synthesis and characterization.
    Lelle M; Frick SU; Steinbrink K; Peneva K
    J Pept Sci; 2014 May; 20(5):323-33. PubMed ID: 24677287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fabrication of pH-Responsive Nanoparticles with an AIE Feature for Imaging Intracellular Drug Delivery.
    Wang X; Yang Y; Zhuang Y; Gao P; Yang F; Shen H; Guo H; Wu D
    Biomacromolecules; 2016 Sep; 17(9):2920-9. PubMed ID: 27442328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2.
    Mansour AM; Drevs J; Esser N; Hamada FM; Badary OA; Unger C; Fichtner I; Kratz F
    Cancer Res; 2003 Jul; 63(14):4062-6. PubMed ID: 12874007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intelligent Nanoprobe: Acid-Responsive Drug Release and In Situ Evaluation of Its Own Therapeutic Effect.
    Yang Y; He Y; Deng Z; Li J; Huang J; Zhong S
    Anal Chem; 2020 Sep; 92(18):12371-12378. PubMed ID: 32786256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metalloprotease-specific poly(ethylene glycol) methyl ether-peptide-doxorubicin conjugate for targeting anticancer drug delivery based on angiogenesis.
    Bae M; Cho S; Song J; Lee GY; Kim K; Yang J; Cho K; Kim SY; Byun Y
    Drugs Exp Clin Res; 2003; 29(1):15-23. PubMed ID: 12866360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Doxorubicin-reinforced supramolecular hydrogels of RGD-derived peptide conjugates for pH-responsive drug delivery.
    Mei L; Xu K; Zhai Z; He S; Zhu T; Zhong W
    Org Biomol Chem; 2019 Apr; 17(15):3853-3860. PubMed ID: 30938396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. P-Sulfocalix[6]arene as Nanocarrier for Controlled Delivery of Doxorubicin.
    Ostos FJ; Lebrón JA; Moyá ML; López-López M; Sánchez A; Clavero A; García-Calderón CB; Rosado IV; López-Cornejo P
    Chem Asian J; 2017 Mar; 12(6):679-689. PubMed ID: 28112869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the anti-cervical cancer effect of a prodrug ：CBZ-AAN-DOX with hypoxic cell culture and tumor-bearing zebrafish models.
    Chen HC; Rui W; You SY; Liu XW; Huang J; Chen HY
    Exp Cell Res; 2020 Jun; 391(1):111980. PubMed ID: 32229193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
    Xu M; Qian J; Liu X; Liu T; Wang H
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
    Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
    Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity.
    Albright CF; Graciani N; Han W; Yue E; Stein R; Lai Z; Diamond M; Dowling R; Grimminger L; Zhang SY; Behrens D; Musselman A; Bruckner R; Zhang M; Jiang X; Hu D; Higley A; Dimeo S; Rafalski M; Mandlekar S; Car B; Yeleswaram S; Stern A; Copeland RA; Combs A; Seitz SP; Trainor GL; Taub R; Huang P; Oliff A
    Mol Cancer Ther; 2005 May; 4(5):751-60. PubMed ID: 15897239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity.
    Zhao Y; Ren W; Zhong T; Zhang S; Huang D; Guo Y; Yao X; Wang C; Zhang WQ; Zhang X; Zhang Q
    J Control Release; 2016 Jan; 222():56-66. PubMed ID: 26682502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release.
    Chen W; Achazi K; Schade B; Haag R
    J Control Release; 2015 May; 205():15-24. PubMed ID: 25445693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.